Bennicas & Associates’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$1.34M Sell
7,576
-100
-1% -$17.3K 0.77% 45
2022
Q3
$1.25M Sell
7,676
-175
-2% -$29.6K 0.8% 45
2022
Q2
$1.39M Hold
7,851
0.81% 45
2022
Q1
$1.39M Buy
7,851
+602
+8% +$102K 0.7% 51
2021
Q4
$1.24M Buy
7,249
+49
+0.7% +$8.02K 0.65% 50
2021
Q3
$1.16M Sell
7,200
-100
-1% -$17.1K 0.65% 58
2021
Q2
$1.2M Hold
7,300
0.66% 55
2021
Q1
$1.2M Hold
7,300
0.69% 54
2020
Q4
$1.15M Hold
7,300
0.67% 55
2020
Q3
$1.09M Hold
7,300
0.68% 51
2020
Q2
$1.03M Hold
7,300
0.77% 44
2020
Q1
$957K Sell
7,300
-450
-6% -$63.8K 0.85% 42
2019
Q4
$1.13M Sell
7,750
-700
-8% -$94.9K 0.82% 46
2019
Q3
$1.09M Hold
8,450
0.85% 43
2019
Q2
$1.18M Sell
8,450
-100
-1% -$13.8K 0.98% 38
2019
Q1
$1.2M Hold
8,550
1.05% 38
2018
Q4
$1.1M Sell
8,550
-325
-4% -$45.3K 1.02% 38
2018
Q3
$1.23M Hold
8,875
1.06% 36
2018
Q2
$1.08M Sell
8,875
-125
-1% -$15.6K 0.96% 45
2018
Q1
$1.15M Hold
9,000
1.03% 41
2017
Q4
$1.26M Sell
9,000
-500
-5% -$69.6K 1.1% 39
2017
Q3
$1.24M Hold
9,500
1.05% 39
2017
Q2
$1.26M Buy
9,500
+75
+0.8% +$9.57K 1.13% 36
2017
Q1
$1.17M Hold
9,425
1.05% 39
2016
Q4
$1.09M Hold
9,425
0.98% 41
2016
Q3
$1.11M Hold
9,425
1.01% 37
2016
Q2
$1.14M Sell
9,425
-250
-3% -$28.4K 1.03% 37
2016
Q1
$1.05M Sell
9,675
-400
-4% -$41.4K 1% 35
2015
Q4
$1.03M Sell
10,075
-4,125
-29% -$415K 1% 40
2015
Q3
$1.33M Sell
14,200
-10,500
-43% -$1.02M 1.24% 32
2015
Q2
$2.41M Buy
24,700
+4,500
+22% +$451K 1.97% 12
2015
Q1
$2.03M Sell
20,200
-200
-1% -$20.3K 1.7% 15
2014
Q4
$2.13M Hold
20,400
1.7% 17
2014
Q3
$2.17M Sell
20,400
-300
-1% -$31.1K 1.79% 15
2014
Q2
$2.17M Hold
20,700
1.69% 14
2014
Q1
$2.03M Sell
20,700
-1,600
-7% -$148K 1.62% 19
2013
Q4
$2.04M Sell
22,300
-2,150
-9% -$198K 1.56% 20
2013
Q3
$2.12M Sell
24,450
-500
-2% -$44.9K 1.53% 23
2013
Q2
$2.14M Buy
+24,950
New +$2.12M 1.48% 26

Other funds holding JNJ

Bennicas & Associates's JNJ Position: Q4 2022 in Review

Bennicas & Associates reduced its Johnson & Johnson (JNJ) stake by 1.3% in Q4 2022, selling an estimated $17.3K and leaving 7,576 shares worth $1.34M. The position accounts for 0.77% of the portfolio, ranked #45.

Bennicas & Associates first reported a position in JNJ in Q2 2013 and has held it in 39 quarters since. The position peaked at $2.41M in Q2 2015. 3,788 funds tracked by Wall St. Rank hold JNJ as of Q4 2022.

  • Bennicas & Associates held 7,576 shares of Johnson & Johnson worth $1.34M as of Q4 2022.
  • Bennicas & Associates sold 100 Johnson & Johnson shares in Q4 2022, an estimated $17.3K.
  • Johnson & Johnson made up 0.77% of Bennicas & Associates's portfolio in Q4 2022, its #45 holding.
  • Bennicas & Associates first reported a position in Johnson & Johnson in Q2 2013 and has held it in 39 quarters since.
  • Bennicas & Associates's Johnson & Johnson position peaked at $2.41M in Q2 2015.
  • 3,788 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2022.

Based on Bennicas & Associates's 13F filing for Q4 2022, filed 12 Jan 2023.